Secreted Frizzled-Related Protein 4 Induces Gastric Cancer Progression and Resistance to Cisplatin and Oxaliplatin via β-Catenin Dysregulation
Chemotherapy · 2024
DOI: 10.1159/000533767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemotherapy, 2024. Verfasst von Chun-Han Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Oxaliplatin, Cisplatin, beta Catenin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Introduction
Gastric cancer is the fifth most common cancer and third leading cause of cancer-related death worldwide. There are three main ways to treat gastric cancer: surgical resection, radiation therapy, and drug therapy. Furthermore, combinations of two to three regimens can improve survival. However, the survival outcomes of chemotherapy in advanced gastric cancer patients are still unsatisfactory. Unfortunately, no widely useful biomarkers have been verified to predict the efficacy of chemotherapy for locally advanced gastric cancer.
Methods
An MTT assay was used to determine the cell viability after cisplatin or oxaliplatin treatment. Western blotting and immunohistochemistry were utilized to examine the secreted frizzled-related protein 4 (sFRP4) level and associated signaling pathways. Immunofluorescence staining was utilized to analyze the location of β-catenin. Colony formation and Transwell assays were used to analyze the functions related with cisplatin, oxaliplatin, and sFRP4.
Results
We have found that gastric cancer patients treated with combinations of 5-fluorouracil (5-FU) and cisplatin regimens have better survival rates than those treated with 5-FU-based chemotherapy alone. sFRP4 was selected as a potential target from stringent analysis and intersection of 5-FU and cisplatin resistance-related gene sets. sFRP4 was shown to be overexpressed in clinical gastric tumor tissues and positively correlated with a worse survival rate. In addition, sFRP4 and β-catenin were upregulated in cisplatin- and oxaliplatin-resistant gastric cancer cells compared to parental cells. Immunofluorescence staining and nuclear fractionation showed that β-catenin was translocated from the cytosol into the nucleus. Moreover, sFRP4 was detected in the conditioned medium of these resistant cells, which indicates that sFRP4 might have an extracellular role in chemotherapy resistance. Increased migration capacity and dysregulation of epithelial-mesenchymal transition-related markers, which might result from the dysregulation of sFRP4, were observed in cisplatin- and oxaliplatin-resistant gastric cancer cells. Discussion/Conclusion: In summary, sFRP4 might play a critical role in resistance to cisplatin and oxaliplatin, cell metastasis, and poor prognosis in gastric cancer via the Wnt-β-catenin pathway. Investigations of the molecular mechanism underlying sFRP4-modulated cancer progression and chemotherapeutic outcomes can provide additional therapeutic strategies for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Biochemistry, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Zitieren
APA
Chen, C. H., Chen, C. J., Huang, Y. C., Huang, P. S., Chi, H. C., Chuang, H. C., Lin, M. H., Huang, T. H., Hsu, J. T., & Chen, C. Y. (2024). Secreted Frizzled-Related Protein 4 Induces Gastric Cancer Progression and Resistance to Cisplatin and Oxaliplatin via β-Catenin Dysregulation. Chemotherapy. https://doi.org/10.1159/000533767
Vancouver
Chen CH, Chen CJ, Huang YC, Huang PS, Chi HC, Chuang HC, et al. Secreted Frizzled-Related Protein 4 Induces Gastric Cancer Progression and Resistance to Cisplatin and Oxaliplatin via β-Catenin Dysregulation. Chemotherapy. 2024. doi:10.1159/000533767
BibTeX
@article{Chen2024,
author = {Chen, Chun-Han and Chen, Chih-Jung and Huang, Yi-Ching and Huang, Po-Shuan and Chi, Hsiang-Cheng and Chuang, Huei-Chieh and Lin, Meng-Hung and Huang, Tzu-Hao and Hsu, Jun-Te and Chen, Cheng-Yi},
title = {Secreted Frizzled-Related Protein 4 Induces Gastric Cancer Progression and Resistance to Cisplatin and Oxaliplatin via β-Catenin Dysregulation},
journal = {Chemotherapy},
year = {2024},
doi = {10.1159/000533767}
}
EUVIMED